The Company has stock-based compensation plans, which are more fully described in Note 12, Stock-Based Compensation, to the Consolidated Financial Statements included in the 2024 10-K. During the three months ended March 31, 2025, the Company granted restricted stock units (“RSUs”) subject to service conditions.

The following table summarizes the activities for all stock options under the Company’s stock-based compensation plans for the three months ended March 31, 2025:


	Number of Options Outstanding	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life	Aggregate Intrinsic Value(1)
	(in thousands)				(in thousands)
Outstanding as of December 31, 2024	4,993	$	0.51	5.09 years	$	589
Granted	—	$	—
Exercised	(4)	$	0.27
Forfeited or expired	(15)	$	0.30
Outstanding as of March 31, 2025	4,974	$	0.51	4.86 years	$	237
Exercisable as of March 31, 2025	4,962	$	0.51	4.86 years	$	237
Vested and expected to vest as of March 31, 2025	4,974	$	0.51	4.86 years	$	237

(1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.

There were no stock options granted during the three months ended March 31, 2025 and 2024. The total intrinsic value of stock options exercised during the three months ended March 31, 2025 and 2024 was immaterial.

As of March 31, 2025, the total unrecognized compensation cost related to all nonvested stock options was immaterial and the related weighted-average period over which it is expected to be recognized was approximately 0.59 years.

The following table summarizes the activities for all RSUs under the Company’s stock-based compensation plans for the three months ended March 31, 2025:


	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Outstanding and nonvested as of December 31, 2024	7,218	$	1.95
Granted	—	$	—
Vested	(469)	$	2.40
Forfeited	(64)	$	1.92
Outstanding and nonvested as of March 31, 2025	6,685	$	1.92

The total vesting date fair value of RSUs which vested during the three months ended March 31, 2025 and 2024 was $0.2 million and $0.7 million, respectively.

As of March 31, 2025, the total unrecognized compensation cost related to all nonvested RSUs was $9.3 million and the related weighted-average period over which it is expected to be recognized was approximately 1.79 years.

The following table provides information about stock-based compensation expense by financial statement line item:


	Three Months Ended
			March 31, 2025		March 31, 2024
		(in thousands)
Platform operations and support			$	213	$	210
Sales and marketing			383		223
General and administrative			1,276		863
Total stock-based compensation expense			$	1,872	$	1,296

Stock-based compensation expense capitalized as part of internal-use software was not material for the three months ended March 31, 2025 and 2024, respectively.